[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500421":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":16,"collaborators":10,"id":18,"slug":10,"hasResults":19,"nctId":20,"briefTitle":21,"officialTitle":21,"acronym":10,"eligibilityCriteria":22,"healthyVolunteers":19,"sex":23,"minAge":24,"maxAge":10,"enrollmentInfo":25,"targetDuration":10,"studyType":28,"phases":10,"briefSummary":29,"conditions":30,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":10},{"fullName":5,"class":6},"Target PharmaSolutions, Inc.","INDUSTRY",[8,12,14],{"label":9,"type":10,"description":11,"interventionNames":10},"Disease Cohort",null,"Observational",{"label":13,"type":10,"description":11,"interventionNames":10},"Engaged Cohort",{"label":15,"type":10,"description":11,"interventionNames":10},"Age Cohort",{"type":17,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100500421",false,"NCT05796037","An Observational Study of Patients Living With Chronic Neurological Diseases","Disease Cohort\n\nInclusion Criteria:\n\n•Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by select ICD-10 codes in the EHR interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent (or have a legally authorized representative to provide informed consent)\n* Care partners may be invited to participate in surveys and will provide informed consent.\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Care partner expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort\n\nAge Cohort\n\nInclusion Criteria:\n\n•Adult patients aged 60 and older at time of enrollment\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years","ALL","18 Years",{"count":26,"type":27},1500000,"ESTIMATED","OBSERVATIONAL","TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).",[31,32,33,34,35,36],"Neurological Diseases or Conditions","Dementia of Alzheimer Type","Alzheimer Disease","Mild Cognitive Impairment","Parkinson Disease","Multiple Sclerosis","NOT_YET_RECRUITING","2024-11-18",{"date":40,"type":41},"2024-11-20","ACTUAL",{"date":43,"type":27},"2025-03-31",{"date":45,"type":27},"2038-12-31",{"name":5,"class":6}]